# FDA Inspection 854295 - Northern Indiana Cancer Research Consortium IRB - November 05, 2013

Source: https://www.keypedia.com/records/fda_inspections/northern-indiana-cancer-research-consortium-irb/0afd7cf6-5ccf-4880-a94e-95f78a6624d8
Source feed: FDA_Inspections

> FDA Inspection 854295 for Northern Indiana Cancer Research Consortium IRB on November 05, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 854295
- Company Name: Northern Indiana Cancer Research Consortium IRB
- Inspection Date: 2013-11-05
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 771895 - 2012-02-21](https://www.keypedia.com/records/fda_inspections/northern-indiana-cancer-research-consortium-irb/ec390355-4ab7-448f-9774-1391d4171ee2)

Company: https://www.keypedia.com/companies/northern-indiana-cancer-research-consortium-irb/c4163fa0-dc6c-4fa8-b7a0-2df7d8b53b45

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c